id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-Z-2200-0004,FDA,FDA-2020-Z-2200,"Termination of the Food and Drug Administration’s Unapproved Drugs Initiative; Request for Information
Regarding Drugs Potentially Generally Recognized as Safe and Effective; Withdrawal",Notice,Withdrawal,2021-05-27T04:00:00Z,2021,5,2021-05-27T04:00:00Z,,2021-05-27T12:13:50Z,2021-11257,0,0,0900006484b3c958
FDA-2020-Z-2200-0003,FDA,FDA-2020-Z-2200,Regulatory Clean Up Initiative; Correction,Rule,Correction,2020-12-17T05:00:00Z,2020,12,2020-12-17T05:00:00Z,,2020-12-18T14:16:54Z,2020-26389,0,0,09000064849a460b
FDA-2020-Z-2200-0002,FDA,FDA-2020-Z-2200,Termination of the Food and Drug Administration's Unapproved Drugs Initiative,Notice,General Notice,2020-11-25T05:00:00Z,2020,11,2020-11-25T05:00:00Z,,2020-11-27T16:25:15Z,2020-26133,0,0,0900006484975dc2
FDA-2020-Z-2200-0001,FDA,FDA-2020-Z-2200,Regulatory Clean Up Initiative,Rule,Policy Statement,2020-11-16T05:00:00Z,2020,11,2020-11-16T05:00:00Z,,2020-11-16T19:24:51Z,2020-21774,0,0,0900006484960499